File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Antifungal and antiviral products of marine organisms

TitleAntifungal and antiviral products of marine organisms
Authors
KeywordsAntifungal
Antiviral
Marine organisms
Products
Issue Date23-Feb-2014
PublisherSpringer
Citation
Applied Microbiology and Biotechnology, 2014, v. 98, n. 8, p. 3475-3494 How to Cite?
Abstract

Marine organisms including bacteria, fungi, algae, sponges, echinoderms, mollusks, and cephalochordates produce a variety of products with antifungal activity including bacterial chitinases, lipopeptides, and lactones; fungal (-)-sclerotiorin and peptaibols, purpurides B and C, berkedrimane B and purpuride; algal gambieric acids A and B, phlorotannins; 3,5-dibromo-2-(3,5-dibromo-2-methoxyphenoxy)phenol, spongistatin 1, eurysterols A and B, nortetillapyrone, bromotyrosine alkaloids, bis-indole alkaloid, ageloxime B and (-)-ageloxime D, haliscosamine, hamigeran G, hippolachnin A from sponges; echinoderm triterpene glycosides and alkene sulfates; molluscan kahalalide F and a 1485-Da peptide with a sequence SRSELIVHQR; and cepalochordate chitotriosidase and a 5026.9-Da antifungal peptide. The antiviral compounds from marine organisms include bacterial polysaccharide and furan-2-yl acetate; fungal macrolide, purpurester A, purpurquinone B, isoindolone derivatives, alterporriol Q, tetrahydroaltersolanol C and asperterrestide A, algal diterpenes, xylogalactofucan, alginic acid, glycolipid sulfoquinovosyldiacylglycerol, sulfated polysaccharide p-KG03, meroditerpenoids, methyl ester derivative of vatomaric acid, lectins, polysaccharides, tannins, cnidarian zoanthoxanthin alkaloids, norditerpenoid and capilloquinol; crustacean antilipopolysaccharide factors, molluscan hemocyanin; echinoderm triterpenoid glycosides; tunicate didemnin B, tamandarins A and B and; tilapia hepcidin 1-5 (TH 1-5), seabream SauMx1, SauMx2, and SauMx3, and orange-spotted grouper β-defensin. Although the mechanisms of antifungal and antiviral activities of only some of the aforementioned compounds have been elucidated, the possibility to use those known to have distinctly different mechanisms, good bioavailability, and minimal toxicity in combination therapy remains to be investigated. It is also worthwhile to test the marine antimicrobials for possible synergism with existing drugs. The prospects of employing them in clinical practice are promising in view of the wealth of these compounds from marine organisms. The compounds may also be used in agriculture and the food industry.


Persistent Identifierhttp://hdl.handle.net/10722/358346
ISSN
2023 Impact Factor: 3.9
2023 SCImago Journal Rankings: 0.957

 

DC FieldValueLanguage
dc.contributor.authorCheung, Randy Chi Fai-
dc.contributor.authorWong, Jack Ho-
dc.contributor.authorPan, Wen Liang-
dc.contributor.authorChan, Yau Sang-
dc.contributor.authorYin, Cui Ming-
dc.contributor.authorDan, Xiu Li-
dc.contributor.authorWang, He Xiang-
dc.contributor.authorFang, Evandro Fei-
dc.contributor.authorLam, Sze Kwan-
dc.contributor.authorNgai, Patrick Hung Kui-
dc.contributor.authorXia, Li Xin-
dc.contributor.authorLiu, Fang-
dc.contributor.authorYe, Xiu Yun-
dc.contributor.authorZhang, Guo Qing-
dc.contributor.authorLiu, Qing Hong-
dc.contributor.authorSha, Ou-
dc.contributor.authorLin, Peng-
dc.contributor.authorKi, Chan-
dc.contributor.authorBekhit, Adnan A-
dc.contributor.authorBekhit, Alaa El-Din-
dc.contributor.authorWan, David Chi Cheong-
dc.contributor.authorYe, Xiu Juan-
dc.contributor.authorXia, Jiang-
dc.contributor.authorNg, Tzi Bun-
dc.date.accessioned2025-08-06T00:30:06Z-
dc.date.available2025-08-06T00:30:06Z-
dc.date.issued2014-02-23-
dc.identifier.citationApplied Microbiology and Biotechnology, 2014, v. 98, n. 8, p. 3475-3494-
dc.identifier.issn0175-7598-
dc.identifier.urihttp://hdl.handle.net/10722/358346-
dc.description.abstract<p>Marine organisms including bacteria, fungi, algae, sponges, echinoderms, mollusks, and cephalochordates produce a variety of products with antifungal activity including bacterial chitinases, lipopeptides, and lactones; fungal (-)-sclerotiorin and peptaibols, purpurides B and C, berkedrimane B and purpuride; algal gambieric acids A and B, phlorotannins; 3,5-dibromo-2-(3,5-dibromo-2-methoxyphenoxy)phenol, spongistatin 1, eurysterols A and B, nortetillapyrone, bromotyrosine alkaloids, bis-indole alkaloid, ageloxime B and (-)-ageloxime D, haliscosamine, hamigeran G, hippolachnin A from sponges; echinoderm triterpene glycosides and alkene sulfates; molluscan kahalalide F and a 1485-Da peptide with a sequence SRSELIVHQR; and cepalochordate chitotriosidase and a 5026.9-Da antifungal peptide. The antiviral compounds from marine organisms include bacterial polysaccharide and furan-2-yl acetate; fungal macrolide, purpurester A, purpurquinone B, isoindolone derivatives, alterporriol Q, tetrahydroaltersolanol C and asperterrestide A, algal diterpenes, xylogalactofucan, alginic acid, glycolipid sulfoquinovosyldiacylglycerol, sulfated polysaccharide p-KG03, meroditerpenoids, methyl ester derivative of vatomaric acid, lectins, polysaccharides, tannins, cnidarian zoanthoxanthin alkaloids, norditerpenoid and capilloquinol; crustacean antilipopolysaccharide factors, molluscan hemocyanin; echinoderm triterpenoid glycosides; tunicate didemnin B, tamandarins A and B and; tilapia hepcidin 1-5 (TH 1-5), seabream SauMx1, SauMx2, and SauMx3, and orange-spotted grouper β-defensin. Although the mechanisms of antifungal and antiviral activities of only some of the aforementioned compounds have been elucidated, the possibility to use those known to have distinctly different mechanisms, good bioavailability, and minimal toxicity in combination therapy remains to be investigated. It is also worthwhile to test the marine antimicrobials for possible synergism with existing drugs. The prospects of employing them in clinical practice are promising in view of the wealth of these compounds from marine organisms. The compounds may also be used in agriculture and the food industry.<br></p>-
dc.languageeng-
dc.publisherSpringer-
dc.relation.ispartofApplied Microbiology and Biotechnology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectAntifungal-
dc.subjectAntiviral-
dc.subjectMarine organisms-
dc.subjectProducts-
dc.titleAntifungal and antiviral products of marine organisms-
dc.typeArticle-
dc.identifier.doi10.1007/s00253-014-5575-0-
dc.identifier.scopuseid_2-s2.0-84898911263-
dc.identifier.volume98-
dc.identifier.issue8-
dc.identifier.spage3475-
dc.identifier.epage3494-
dc.identifier.eissn1432-0614-
dc.identifier.issnl0175-7598-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats